baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

MAGELLAN C/ FR0000292278 /

NAV2024-05-07	Chg.+0.0900	Type of yield	Investment Focus	Investment company
19.9200EUR	+0.45%	reinvestment	Equity Emerging Markets	Comgest ▶

GlobeNewswire 04-24 Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...

GlobeNewswire 04-08 Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...

GlobeNewswire 04-01 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...

GlobeNewswire 03-27 Cegedim Full year 2023 results: Revenue and recurring operating income both up

GlobeNewswire 03-26 Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

GlobeNewswire 03-15 Gain Therapeutics to Present at Public Ventures Discovery Day

GlobeNewswire 03-05 Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action ...

GlobeNewswire 03-05 Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

GlobeNewswire 02-27 Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 ...

GlobeNewswire 02-20 Diamondback Energy, Inc. Announces Fourth Quarter and Full Year 2023 Financial and Operating Results

GlobeNewswire 02-20 Giant Magellan Telescope Expands Global Science Impact with Taiwanese Partner

GlobeNewswire 02-14 Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight

GlobeNewswire 02-13 Navios Maritime Partners L.P. Reports Financial Results for the Fourth Quarter and Year Ended Decemb...

GlobeNewswire 02-06 UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson...

GlobeNewswire 02-06 Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Diseas...

GlobeNewswire 01-31 Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update

GlobeNewswire 01-30 National Academy of Social Insurance Welcomes Fifty-Three New Members

GlobeNewswire 01-18 inGroup Celebrates Record-Breaking 2023, 8th Anniversary On Historic “Elevate Cruise”

GlobeNewswire 2023-12-29 Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...

GlobeNewswire 2023-12-05 Talkspace Announces Appointment of Two New Independent Directors

GlobeNewswire 2023-11-29 Workhorse Group Expands Dealer Network to Eight Partners Nationwide

GlobeNewswire 2023-11-09 CIO Leadership: The Transformational Implications of AI will Power the Discussion at the 2023 Housto...

GlobeNewswire 2023-11-09 Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

GlobeNewswire 2023-11-06 Diamondback Energy, Inc. Announces Third Quarter 2023 Financial and Operating Results

GlobeNewswire 2023-11-02 Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended ...

MAGELLAN C/ FR0000292278 /

If you wish to receive reply to your feedback, please provide your email address.